Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-349,679
Closed -$5.14M 4214
2025
Q3
$5.14M Buy
349,679
+107
+0% +$1.09K ﹤0.01% 2300
2025
Q2
$3.43M Buy
349,572
+39,656
+13% +$328K ﹤0.01% 2482
2025
Q1
$2.25M Buy
309,916
+61,760
+25% +$540K ﹤0.01% 2636
2024
Q4
$1.94M Buy
248,156
+9,314
+4% +$76.7K ﹤0.01% 2772
2024
Q3
$1.77M Sell
238,842
-60,847
-20% -$512K ﹤0.01% 2817
2024
Q2
$2.4M Buy
299,689
+50,943
+20% +$455K ﹤0.01% 2696
2024
Q1
$2.9M Buy
248,746
+26,326
+12% +$291K ﹤0.01% 2572
2023
Q4
$2.48M Buy
222,420
+4,515
+2% +$41.5K ﹤0.01% 2722
2023
Q3
$3.36M Sell
217,905
-10,114
-4% -$170K ﹤0.01% 2530
2023
Q2
$4.32M Buy
228,019
+182,742
+404% +$3.21M ﹤0.01% 2400
2023
Q1
$690K Buy
45,277
+18,194
+67% +$237K ﹤0.01% 3317
2022
Q4
$345K Buy
27,083
+10,580
+64% +$95.2K ﹤0.01% 3734
2022
Q3
$96K Buy
+16,503
New +$72.5K ﹤0.01% 4204
2022
Q2
Sell
-30,632
Closed -$116K 4622
2022
Q1
$116K Sell
30,632
-799
-3% -$5.15K ﹤0.01% 4380
2021
Q4
$411K Buy
31,431
+772
+3% +$12.2K ﹤0.01% 3919
2021
Q3
$600K Buy
30,659
+2,112
+7% +$38.6K ﹤0.01% 3705
2021
Q2
$533K Buy
28,547
+7,089
+33% +$158K ﹤0.01% 3741
2021
Q1
$508K Sell
21,458
-1,409
-6% -$32.5K ﹤0.01% 3680
2020
Q4
$557K Buy
22,867
+7,002
+44% +$179K ﹤0.01% 3564
2020
Q3
$407K Buy
+15,865
New +$503K ﹤0.01% 3581
2020
Q2
Sell
-9,737
Closed -$246K 4107
2020
Q1
$246K Buy
+9,737
New +$285K ﹤0.01% 3673

Other funds holding ETNB

Bank of New York Mellon's ETNB Position: Q4 2025 in Review

Bank of New York Mellon sold out of 89bio (ETNB) in Q4 2025, closing a stake of 349,679 shares — an estimated $5.14M sold.

Bank of New York Mellon first reported a position in ETNB in Q1 2020 and held it in 21 quarters. The position peaked at $5.14M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Bank of New York Mellon reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Bank of New York Mellon sold 349,679 89bio shares in Q4 2025, an estimated $5.14M.
  • Bank of New York Mellon first reported a position in 89bio in Q1 2020 and held it in 21 quarters.
  • Bank of New York Mellon's 89bio position peaked at $5.14M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Bank of New York Mellon's 13F filing for Q4 2025, filed 10 Feb 2026.